Suite 1300
Salt Lake City, UT 84111
Block-1 3rd Floor, Perungudi Bypass Rd, Perungudi,
Chennai - 600096
MGR Main Rd,
Perungudi, Chennai - 600096
Villupuram,
Tamil Nadu – 605602
Specialty Drug Exception Requests
Formulary, Tier, and Non-Formulary
Exceptions That Actually Get Approved
Formulary exception, tier exception, and non-formulary drug exception requests with the clinical and economic justification specific to each plan's exception protocol — across commercial, Medicare Part D, Medicare Advantage, and managed Medicaid carriers.
85%+
Exception Approval Rate
< 72 HR
HR Expedited Standard
ALL EXCEPTION
Types Covered
The Reality
Why drug exception requests are a different discipline from prior authorization?
Three Distinct Exception Types
Formulary exceptions (non-formulary drug), tier exceptions (reduce patient cost-sharing), and quantity limit exceptions each follow different regulatory pathways and require different justification. Treating them with a generic exception workflow produces high denial rates.
Medicare Part D Exception Rules Differ from Commercial
Medicare Part D exception requests follow specific CMS regulatory protocols — 72-hour standard turnaround, 24-hour expedited, defined clinical criteria, and prescriber statement requirements. Commercial plans operate under their own exception rules with state insurance regulations layered on top.
Cost-Sharing vs. Clinical Justification
Tier exception requests succeed or fail on whether the cost-sharing argument is made correctly — patient financial hardship documentation, comparable agent affordability comparison, adherence risk analysis. Clinical justification alone isn't sufficient for tier exceptions.
Patient Financial Toxicity Is the Trigger
Most exception requests originate from patient financial toxicity — out-of-pocket cost on the formulary alternative is too high, or the non-formulary drug is the only effective option. Exception workflow needs to capture and document the financial reality, not just the clinical case.
Multiple Exception Submissions per Patient
A single specialty patient may need formulary, tier, AND quantity limit exceptions on the same therapy. Each requires its own submission, its own justification, and its own approval. Coordinated exception management isn't a luxury — it's the only way to get the patient on therapy.
CMS 2024 Part D Exception Updates
CMS 2024 Medicare Part D rules tightened exception request timelines and clinical documentation standards. Pharmacies running exception workflows on pre-2024 protocols face higher denial rates and missed expedited windows.
Our approach
We run exception requests as a distinct operational discipline
AnnexMed runs specialty drug exception requests as a dedicated operation separate from standard prior authorization — with exception-type-specific workflows for formulary, tier, and quantity limit exceptions, CMS Medicare Part D regulatory protocols, commercial plan-specific exception pathways, and coordinated patient financial documentation. Exception requests get treated as the distinct discipline they are.
We serve specialty pharmacies, infusion centers, and home infusion providers where formulary restrictions, tier placement, and quantity limits actively block patient access to effective specialty therapy. Our team manages exception requests across Medicare Part D, Medicare Advantage, the top 40 commercial plans, and managed Medicaid carriers — with exception-type-specific clinical and economic justification protocols pre-built.
Recent client results
A specialty pharmacy serving Medicare Part D patients improved formulary exception approval rate from 56% to 86% within 90 days of go-live, expanding access to high-cost specialty therapy for approximately 340 patients per year who would otherwise face formulary blocks. A regional infusion provider serving commercial immunology patients reduced tier exception turnaround from 9.4 days to 2.8 days through coordinated patient financial documentation and plan-specific economic justification. A specialty pharmacy with strong rare disease focus eliminated $580,000 in annual revenue loss from formulary blocks on orphan drugs through dedicated exception capability and proactive non-formulary advocacy.
85%+
Exception Approval
Rate
< 72 hrs
Medicare Part D Standard
Turnaround
< 24 hrs
Medicare Part D Expedited Standard
How we support you
End-to-End exception request operation
Exception Analysis
Type and pathway selection
- Exception type identification (formulary/tier/QL)
- Plan-specific exception pathway lookup
- Medicare Part D vs. commercial routing
- Expedited vs. standard determination
- Multi-exception coordination per patient
- Comparable agent affordability analysis
Justification Assembly
Clinical and economic evidence
- Clinical justification per exception criteria
- Patient financial toxicity documentation
- Comparable agent failure or affordability comparison
- Prescriber statement coordination
- Adherence risk analysis for tier exceptions
- Prior treatment history compilation
Submission & Escalation
Through final approval
- Plan-specific exception submission
- Expedited window capture for urgent cases
- Status tracking through adjudication
- Denial appeals with refined justification
- External review escalation for Part D denials
- Approval-to-claim status operationalization
Financial impact
What exception request capability means in dollars?
For a specialty pharmacy where formulary blocks and tier placement actively limit patient access to effective therapy, dedicated exception request operations regularly deliver $700K–$2.5M+ in net annual financial benefit through expanded therapy access, reduced patient abandonment from cost barriers, and recovered revenue from previously blocked specialty fills. Most pharmacies achieve full ROI on exception operations within 4–6 months.
Fast Results
Exception approval improvement shows within the first 60 days as exception-type-specific workflows replace generic PA-style submissions. Revenue from previously blocked formulary fills typically begins paying back inside 90 days.
CMS 2024 Part D Compliant
Improvement Area
Estimated Annual Impact
Formulary Exception Approval Improvement (56% → 86%)
$400K – $1.5M annually in newly accessible therapy
Tier Exception Recovery
$200K – $800K annually in reduced patient abandonment
Quantity Limit Exception Capture
$150K – $500K annually in proper-quantity dispensing
Expedited Window Capture (urgent cases)
$100K – $400K annually in therapy-start preservation
Multi-Exception Patient Recovery
$150K – $500K annually in patients with combined exceptions
External Review Escalation Capture
$80K – $350K annually in Part D second-level overturns
Staffing Cost Reduction / Replacement
$170K – $420K annually
Exception request performance targets
Performance Metric
Industry Benchmark
AnnexMed Target
Overall Exception Approval Rate
Specialty avg: 54–64%
85%+
Medicare Part D Standard Turnaround
CMS requirement; industry compliance varies
< 72 hours
Medicare Part D Expedited Turnaround
CMS requirement; capture rate varies
< 24 hours
Tier Exception Approval Rate
Specialty avg: 48–58%
82%+
Quantity Limit Exception Approval
Specialty avg: 62–74%
88%+
Multi-Exception Patient Coordination
Industry: rarely coordinated
Standard practice
Patient Financial Documentation Completeness
Industry avg: 58–72%
98%+
External Review Pursuit on Denials
Industry: rarely pursued
Standard
Why Annexmed?
In-house exception submission vs. Annexmed operation
Exception requests are where formulary blocks, tier barriers, and quantity restrictions get cleared or quietly absorb specialty pharmacy revenue. Here’s how AnnexMed compares to typical in-house or generalist PA operations:
In-House / Traditional
AnnexMed Partnership
Exception Type Discipline
Generic PA-style workflow for all exception types
Type-specific workflows for formulary, tier, and quantity limit exceptions
Medicare Part D Compliance
Many operations on pre-2024 protocols
CMS 2024 Part D rules with current timeline and documentation standards
Financial Justification
Clinical justification only; tier exceptions fail at high rates
Combined clinical + economic justification per exception type
Approval Rate
54–64% across exception types
85%+ with exception-type-specific justification
Multi-Exception Coordination
Each exception submitted independently
Coordinated workflow for patients needing multiple exceptions
Expedited Window Capture
Frequently missed on urgent cases
Same-day capture for 24-hour expedited Part D and equivalent commercial
External Review Pursuit
Rarely used on exception denials
Standard escalation for Part D denied exception requests
Cost to Operate
$85K–$120K per FTE for PA + clinical coordinator
30–40% lower with no hiring, attrition, or training overhead
Technology
Powered by proprietary AI & analytics
AnnexMed’s technology stack was built for payer-specific operational demands, not adapted from provider-side billing tools. Risk adjustment accuracy, payment integrity, and credentialing compliance each require different data models, workflow logic, and reporting architectures than provider RCM. Our platform reflects that.
AI Agents & Automation
AI Agents & Intelligent Automation deploys autonomous AI agents across the full revenue cycle, automating eligibility verification, prior authorization, claims processing, payment posting, and denial management at hospital scale and speed.
Data & Analytics Platform
Data & Analytics Platform delivers real-time Power BI dashboards built for hospital executive visibility, including system-wide KPIs, service line performance, payer analysis, productivity, financial forecasting, and national benchmarking insights.
Intelligent AR Management
Intelligent AR Management handles A/R follow-up at hospital scale with intelligent worklists prioritized by dollar value and aging, payer-specific follow-up rules, automated escalation for high-value accounts, and full accountability for every claim.
Computer Assisted Coding
Computer Assisted Coding orchestrates hospital coding operation, intelligent chart assignment by service line, TAT tracking with SLA monitoring, quality audits with accuracy scoring, and coder performance management at enterprise scale.
Together, these platforms create a fully instrumented RCM operation where nothing falls through the cracks. You don’t interact with these systems directly, but the results they enable show up directly in your financial performance.
Ready to clear the formulary blocks limiting your specialty patients' access?
Trusted by 100+ Healthcare Providers | AAPC, AHIMA & AAHAM Certified | SOC 2 Type II | HIPAA Compliant
Payer client outcomes
$15M–$40M
Risk
Adjustment
$18M–$50M
Payment
Integrity
6 Weeks
Credentialing Clearance
$15M–$50M+
Revenue
Impact
Case Studies
See the impact we deliver
Discover how AnnexMed reduces denials, accelerates reimbursements, and strengthens financial performance. Backed by measurable outcomes and proven RCM expertise, we deliver operational excellence, revenue stability, and sustainable growth you can trust.
Client Voices
See how our clients succeed
Proven RCM expertise. Delivered at scale.
For over 20 years, AnnexMed has delivered RCM solutions nationwide, combining expert billing, coding, and AR support to drive measurable results and growth.
- 20+ years of proven healthcare RCM experience
- 1,500+ professionals supporting billing, coding & AR
- 500+ certified coders across multiple specialties
- 99%+ compliance with HIPAA and security standards
- All 50 states served with consistent, scalable operations
